Results 171 to 180 of about 1,649 (205)
Some of the next articles are maybe not open access.
Severe gastrointestinal bleeding secondary to lornoxicam in the dog
Schweizer Archiv fur Tierheilkunde, 2011Six dogs with lornoxicam induced severe gastrointestinal bleeding are described. The ingested dose ranged between 0.5 - 5.1 mg/kg BW (median 0.63 mg/kg BW). The severity of the bloodloss anemia was moderate to severe with PCV values ranging between 12 - 27 % (median 16 %) and serum albumin concentrations between 12 - 22 g/l (median 16 g/l). One dog had
Kook, Peter H, Reusch, Claudia E
openaire +2 more sources
Antithrombotic potential of lornoxicam and possible mechanistic pathways
The Journal of Pharmacology and Experimental TherapeuticsLornoxicam is traditionally used as an anti-inflammatory and analgesic drug. Recent studies suggest that nonsteroidal anti-inflammatory drugs can influence platelet and coagulation pathways. However, the antithrombotic and cardiopulmonary protective potential of lornoxicam remains unexplored.
Waseem, Khalid +2 more
openaire +2 more sources
Clinical pharmacokinetic studies with lornoxicam.
Postgraduate medical journal, 1991Pharmacokinetic data from several studies in young and elderly human subjects are reviewed. Lornoxicam appears to be extensively metabolized and no unchanged drug has been found in the urine. It has a relatively short elimination half-life (about 4 hours), and no significant differences in pharmacokinetic data have been found between young and elderly ...
P, Turner, A, Johnston
openaire +1 more source
Anaphylactic Paradox: Is it Lornoxicam or Neostigmin ?
2013Kelimeler: Kolesistektomi ...
ERGÜL, Dursun Fırat, DURMAZ, Funda
openaire +1 more source
121. Epidural Lornoxicam Administration- Innocent
Regional Anesthesia & Pain Medicine, 2008H AKTUG +7 more
openaire +1 more source